Emerging influenza antiviral resistance threats

J Infect Dis. 2011 Jan 1;203(1):6-10. doi: 10.1093/infdis/jiq012.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adamantane / pharmacology*
  • Antiviral Agents / pharmacology*
  • Drug Resistance, Multiple, Viral*
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / growth & development
  • Influenza A Virus, H1N1 Subtype / pathogenicity
  • Influenza A Virus, H1N1 Subtype / physiology*
  • Influenza, Human / virology*
  • Mutation, Missense
  • Oseltamivir / pharmacology*
  • Reassortant Viruses / drug effects
  • Reassortant Viruses / growth & development
  • Reassortant Viruses / pathogenicity
  • Reassortant Viruses / physiology
  • Virus Replication

Substances

  • Antiviral Agents
  • Oseltamivir
  • Adamantane